Hemostemix Inc.
HEM.VTSXVHealthcare● Active
$0.06
+$0.01(+10.00%)
Market Cap$10878805
P/E Ratio—
52W High$0.16
52W Low$0.04
Hemostemix Inc.（HEM.V）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · HEM.V · 截至 Jun 8, 2026
关键指标
探索 Hemostemix Inc. 数据
hem.v stock data · financials财务快照
完整财报FY 2025Revenue$0.00
202320242025
hemostemix inc. revenue · hem.v revenue 2025FY 2025Net Income-$4.7M▼ 80.20% YoY
202320242025
hemostemix inc. net income · hem.v profit 2025FY 2025EPS$-0.03▼ 4.73% YoY
202320242025
hem.v eps · hemostemix inc. earnings per share 2025竞争对手与同行
hem.v competitors#TickerCompanyPriceChangeMkt Cap
#1HEM.VHemostemix Inc.
$0.06+10.00%$10.9M#2
BLAB.CNBritannia Life Sciences Inc.
$0.09+0.00%$13.8M#3
DOSE.CNRapid Dose Therapeutics Corp.
$0.09-5.26%$11.9M#4
MDMA.CNPharmala Biotech Holdings Inc.
$0.15+3.70%$15.8M#5
MRVL.VMarvel Biosciences Corp.
$0.22+2.56%$13.9M#6
NARA.CNPangenomic Health Inc.
$0.33-12.00%$4.6M股票表现
完整历史1D+10.00%
1W-8.33%
1M-8.33%
3M-31.25%
YTD-38.89%
1Y-54.17%
5Y-78.43%
关于 Hemostemix Inc.
Hemostemix Inc. a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patie…
what is hemostemix inc. · hem.v stock overview · hemostemix inc. company profile · who is hemostemix inc. ceo · hem.v TSXV · hemostemix inc. headquarters · hemostemix inc. business segments
关于股票概览与关键数据
Hemostemix Inc.（HEM.V）是 Biotechnology 行业的 Healthcare 类公司，于 Nov 28, 2014 在 TSXV 上市。截至最近交易日，HEM.V 股价为 $0.06，市值约为 $10.9M。过去12个月累计回报 -54.17%，年初至今回报 -38.89%。
2025 财年 Hemostemix Inc. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。
常见问题
截至最近一个交易日，Hemostemix Inc.（HEM.V）股价为 $0.06，在 TSXV 上市，52周区间为 $0.04 – $0.16。
HEM.V 最新股价HEM.V quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议